Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting

dc.contributor.author	Council for International Organizations of Medical Sciences (CIOMS)
dc.date.accessioned	2020-06-19T11:28:10Z
dc.date.available	2020-06-19T11:28:10Z
dc.date.issued	2020
dc.identifier.uri	http://hdl.handle.net/10062/68140
dc.language	inglise keeles	et
dc.language.iso	eng	et
dc.publisher	Geneva. Council for International Organizations of Medical Sciences (CIOMS)	et
dc.rights	openAccess	et
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject.other	farmakoloogia	et
dc.subject.other	gastroenteroloogia	et
dc.subject.other	hepatoloogia	et
dc.subject.other	maksakahjustused	et
dc.subject.other	ravimid	et
dc.subject.other	tervishoiukorraldus	et
dc.subject.other	ravimite kõrvaltoimed	et
dc.title	Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting	et
dc.type	Book	et